L’intelligenza artificiale nel percorso diagnostico terapeutico delle malattie rare: facciamo il punto…
Medico e Bambino · 15.04.2026 · 45 (4) · 235-240
DOI: 10.53126/meb45235 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medico e Bambino, erschienen am 15.04.2026. Verfasst von Federica Casieri und 2 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Artificial Intelligence (AI) is playing an increasingly pivotal role in the field of rare diseases, where diagnostic complexity and the limited availability of therapeutic options still pose significant challenges. Machine learning and deep learning models are now widely employed in clinical genetics and offer a valuable support throughout the diagnostic process: from assisting in the phenotypic recognition, to analysing/processing genomic data and interpreting genetic variants. In the field of dysmorphology advanced facial recognition tools, such as ‘Face2Gene’, have showed a remarkable ability to recognise phenotypic features associated with rare genetic conditions. Therefore, diagnostic precision has been substantially enhanced and more patients have been able to receive timely and accurate evaluations (thereby reducing the ‘diagnostic odyssey’ that affects many patients with ultra-rare conditions). AI is also a strategic resource to use innovative therapies, namely drug repurposing strategies that enable to identify new indications for already approved drugs and reduce research and development overall burden in an effective and automated way. The application of AI-based tools opens up new perspectives on personalised therapy, as it enables the correlation of patients’ clinical, biochemical and genomic data and leads to the proposal of individualised interventions. Starting from a clinical report in which the application of facial recognition tools has led to a definitive diagnosis, the article aims to describe the current state of the art and the future perspective for AI in the field of medical genetics.
Zitieren
APA
Casieri, F., vitale, D., & Selicorni, A. (2026). L’intelligenza artificiale nel percorso diagnostico terapeutico delle malattie rare: facciamo il punto…. Medico e Bambino, 45(4), 235-240. https://doi.org/10.53126/meb45235
Vancouver
Casieri F, vitale D, Selicorni A. L’intelligenza artificiale nel percorso diagnostico terapeutico delle malattie rare: facciamo il punto…. Medico e Bambino. 2026;45(4):235-240. doi:10.53126/meb45235
BibTeX
@article{Casieri2026,
author = {Casieri, Federica and vitale, Daniele and Selicorni, Angelo},
title = {L’intelligenza artificiale nel percorso diagnostico terapeutico delle malattie rare: facciamo il punto…},
journal = {Medico e Bambino},
year = {2026},
volume = {45},
number = {4},
pages = {235--240},
doi = {10.53126/meb45235}
}
EUVIMED